Earlier last month, MedeAnalytics announced that Wise Health System, based in Decatur, Texas and affiliated with Baylor Scott & White Health, will expand its partnership with MedeAnalytics by leveraging its analytics platform and deep financial expertise across all segments of the revenue cycle – patient access, mid-cycle and the business office.
Following the announcement, Lynn Giddens-Branscum, Revenue Cycle Director at Wise Health System, spoke with Jacqueline DiChiara of RevCycleIntelligence.com to offer her perspective on the following:
- how providers and patients alike are left behind when revenue cycle snares ensue
- where top industry focuses are as the end of 2015 comes to a close
During the interview, Lynn also discussed how Wise Health System is striving to gain a more holistic view into their revenue cycle with the help of MedeAnalytics to improve their real-time data collection and point-of-service endeavors.
For example, “helping patients better understand the caveats within their policies so they'll have a realistic expectation of what their patient portions are going to be helps the revenue cycle.”
For additional insights from Wise Health System, check out the complete article here.
Get our take on industry trends
Providers: Are you ready to be audited?
By Donna Kennedy In 2020, regular audits conducted by CMS and other payers were paused or significantly reduced as the…
Read on...From Insights to Action – The Digital Transformation of Healthcare in the Post-Pandemic “New Normal”
In November, MedeAnalytics hosted the 2021 Impact Summit, an engaging and educational event held annually and designed exclusively for our…
Read on...2022 Rx: Your new, post-pandemic prescription for success
By Dave Schweppe, Chief Analytics Officer, MedeAnalytics Despite the common use of the term “post-COVID,” most leaders across the healthcare…
Read on...Combating the opioid epidemic in North America with Nobel Prize winning research
American Researchers Dr. David Julius and Dr. Ardem Patapoutian from California were awarded the Nobel Prize in medicine for their path breaking work on the development of non-opioid painkillers, showing immense promise for combating the epidemic.
Read on...